Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of AZD8154 Nebuliser vs DPI in Healthy Subjects
NCT04480879Phase 1Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AZD8154 in asthma (3 arms), sponsored by AstraZeneca. Primary endpoints: Area under the plasma concentration time curve from zero to infinity, Area under the plasma concentration time curve from time zero to time of last quantifiable concentration and 1 more. Started Jul 2020; status: terminated.
02
Drugs
AZD8154
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04480879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04480879.